1. Home
  2. ENTA vs RILY Comparison

ENTA vs RILY Comparison

Compare ENTA & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$10.94

Market Cap

303.8M

Sector

Health Care

ML Signal

N/A

RILY

B. Riley Financial Inc.

N/A

Current Price

$3.47

Market Cap

349.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
RILY
Founded
1995
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
303.8M
349.8M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
ENTA
RILY
Price
$10.94
$3.47
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $21.83
N/A
AVG Volume (30 Days)
244.8K
★ 842.2K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
★ 138.49
EPS
N/A
★ N/A
Revenue
$102,814,000.00
★ $967,599,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 16.48
15.38
52 Week Low
$10.01
$3.49
52 Week High
$17.15
$11.24

Technical Indicators

Market Signals
Indicator
ENTA
RILY
Relative Strength Index (RSI) 45.83 31.83
Support Level $10.01 N/A
Resistance Level $13.94 $4.54
Average True Range (ATR) 0.80 0.30
MACD 0.08 0.03
Stochastic Oscillator 41.51 6.25

Price Performance

Historical Comparison
ENTA
RILY

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About RILY B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.

Share on Social Networks: